Release 4 FHIR CI-Build

This page is part of the Continuous Integration Build of FHIR Specification (v4.0.1: R4 - Mixed Normative and STU ) in it's permanent home (it will always (will be available incorrect/inconsistent at this URL). The current version which supercedes this version is 5.0.0 . For a full list of available versions, see times).
See the Directory of published versions . Page versions: R5 R4B R4 R3

Medicationadministration0310.xml

Example MedicationAdministration/medadmin0310 (XML)

Maturity Level : N/A
Responsible Owner: Pharmacy Work Group Standards Status : Informative Compartments : Device , Encounter , Group , Patient , Practitioner , RelatedPerson

Raw XML ( canonical form + also see XML Format Specification )

Jump past Narrative

Oral Chemotherapy - Myleran (id = "medadmin0310") 

<?xml version="1.0" encoding="UTF-8"?>

 
  
  (Details : {http://hl7.org/fhir/sid/ndc code '76388-713-25' = 'n/a', given as 'Myleran
           2mg tablet, film coated'})6 mg PO daily for remission induction; adjust dosage to white blood cell (WBC) count.
              With hold treatment if WBC is less than 15,000/µL; resume when WBC is greater than 50,000/µL(Details : {SNOMED CT code '26643006' = 'Oral route', given as 'Oral route (qualifier
               value)'})
      
      
        
          
          
          
        
      
  
  
  
  
    
  
 
   
    
  
 
  
   

  
    
      
      
    
  
  
    
  
  
    6 mg PO daily for remission induction; adjust dosage to white blood cell (WBC) count.
      With hold treatment if WBC is less than 15,000/µL; resume when WBC is greater than 50,000/µL
    
      
        
        
        
      
    
    
      
      
      
      
    
  

<MedicationAdministration xmlns="http://hl7.org/fhir">
  <id value="medadmin0310"/> 
  <contained> 
    <Medication> 
      <id value="med0304"/> 
      <code> 
        <coding> 
          <system value="http://hl7.org/fhir/sid/ndc"/> 
          <code value="76388-713-25"/> 
          <display value="MYLERAN, 25 TABLET, FILM COATED in 1 BOTTLE (76388-713-25) (package)"/> 
        </coding> 
        <text value="Myleran 2mg tablet, film coated"/> 
      </code> 
    </Medication> 
  </contained> 
  <status value="completed"/> 
  <medication> 
    <reference> 
      <reference value="#med0304"/> 
    </reference> 
  </medication> 
  <subject> 
    <reference value="Patient/pat1"/> 
    <display value="Donald Duck"/> 
  </subject> 
  <occurrencePeriod> 
    <start value="2015-01-15T22:03:00+01:00"/> 
    <end value="2015-01-16T02:03:00+01:00"/> 
  </occurrencePeriod> 
  <performer> 
    <actor> 
      <reference> 
        <reference value="Practitioner/f007"/> 
        <display value="Patrick Pump"/> 
      </reference> 
    </actor> 
  </performer> 
  <request> 
    <reference value="MedicationRequest/medrx0306"/> 
  </request> 
  <dosage> 
    <text value="6 mg PO daily for remission induction; adjust dosage to white blood cell (WBC)
     count.  With hold treatment if WBC is less than 15,000/µL; resume when WBC is greater
     than 50,000/µL"/> 
    <route>       <coding>         <system value="http://snomed.info/sct"/>         <code value="26643006"/>         <display value="Oral route (qualifier value)"/>       </coding>     </route>     <dose>       <value value="6"/>       <unit value="mg"/>       <system value="http://unitsofmeasure.org"/>       <code value="mg"/>     </dose>   </dosage> 


</

MedicationAdministration

>

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.